Rifaximin (an antibiotic) treatment of acute alcoholic liver injury.

Registry ID

EUCTR2014-002264-33

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

Ole Hamberg

Start date

2014-08-25

Completion date

2018-05-11

Last update

2026-08-16

Conditions

• Alcoholic hepatitis.

Summary

Rifaximin treatment reduces various complications to liver disease. In this trial we wish to investigate the potentiel metabolic and inflammatory changes in the blood of patients with alcoholic hepatitis receiving rifaximin therapy.

Locations

• , , Denmark

View on source registry